6-amino(aza)indane compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor

Details for Australian Patent Application No. 2005293693 (hide)

Owner Abbott GmbH & Co. KG

Inventors Grandel, Rolan; Unger, Liliane; Braje, Wilfried; Drescher, Karla; Turner, Sean C.; Haupt, Andreas

Agent Spruson & Ferguson

Pub. Number AU-B-2005293693

PCT Pub. Number WO2006/040177

Priority 60/618,743 14.10.04 US

Filing date 14 October 2005

Wipo publication date 20 April 2006

Acceptance publication date 17 November 2011

International Classifications

C07C 311/21 (2006.01) Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups

A61K 31/18 (2006.01) - Sulfonamides

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

A61P 25/18 (2006.01) Drugs for disorders of the nervous system

C07D 221/06 (2006.01) Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups

C07D 239/38 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

C07D 333/34 (2006.01) Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 409/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

Event Publications

31 May 2007 PCT application entered the National Phase

  PCT publication WO2006/040177 Priority application(s): WO2006/040177

17 September 2009 Amendment Made

  The nature of the amendment is: Amend applicant name from Abbott GmbH & Co.KG to Abbott GmbH & Co. KG

17 November 2011 Application Accepted

  Published as AU-B-2005293693

15 March 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005293694-Arylsulfonylmethyl or arylsulfonamide substituted aromatic compounds suitable for treating disorders that respond to madulation of the dopamine D3 receptor

2005293678-Intracardiac blood pump